Home
SLDB
SLDB News

Latest Solid Biosciences Inc. (SLDB) News on April 2, 2025

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

21 hours ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

GlobeNewswire

a day ago

Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

Solid Biosciences Inc. (SLDB): Among Top Insider Purchases Last Month

Insider Monkey

18 days ago

Solid Biosciences Inc. (SLDB): Among Top Insider Purchases Last Month

Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

GlobeNewswire

21 days ago

Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Wall Street Analysts Believe Solid Biosciences (SLDB) Could Rally 198.18%: Here's is How to Trade

Zacks

a month ago

Wall Street Analysts Believe Solid Biosciences (SLDB) Could Rally 198.18%: Here's is How to Trade

SLDB Stock Rallies 60% in a Month: Here's What You Should Know

Zacks

a month ago

SLDB Stock Rallies 60% in a Month: Here's What You Should Know

Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire

a month ago

Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire

a month ago

Solid Biosciences to Participate at Upcoming Investor Conferences

Is Solid Biosciences Inc. (SLDB) Among Stocks With At Least $20 Million In Insider Spending Recently?

Insider Monkey

a month ago

Is Solid Biosciences Inc. (SLDB) Among Stocks With At Least $20 Million In Insider Spending Recently?

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a month ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences Inc.'s (NASDAQ:SLDB) stock price dropped 11% last week; individual investors would not be happy

Simply Wall St.

a month ago

Solid Biosciences Inc.'s (NASDAQ:SLDB) stock price dropped 11% last week; individual investors would not be happy

MT Newswires

a month ago

Wedbush Adjusts Price Target on Solid Biosciences to $18 From $16, Keeps Outperform Rating

Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News

Zacks

a month ago

Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News

Solid Biosciences’ stock soars on early success in DMD gene therapy trial

Clinical Trials Arena

a month ago

Solid Biosciences’ stock soars on early success in DMD gene therapy trial

MT Newswires

a month ago

Solid Biosciences Shares Up After Positive Results From Duchenne Drug Study, Prices $200 Million Offering

MT Newswires

a month ago

Top Midday Gainers

Solid Biosciences Announces Pricing of Underwritten Offering

GlobeNewswire

a month ago

Solid Biosciences Announces Pricing of Underwritten Offering

Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003

GlobeNewswire

a month ago

Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003

Solid says early data suggest ‘differentiated’ Duchenne gene therapy

BioPharma Dive

a month ago

Solid says early data suggest ‘differentiated’ Duchenne gene therapy

Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks

TipRanks

2 months ago

Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

2 months ago

Solid Biosciences Gets Fast Track Designation for Potential Friedreich's Ataxia Treatment

Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

GlobeNewswire

2 months ago

Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

MT Newswires

3 months ago

Solid Biosciences Outlines Key Priorities at Healthcare Conference

Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines

GlobeNewswire

3 months ago

Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines

Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

3 months ago

Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SLDB Stock Up as FDA Clears IND for SGT-212 in Friedreich's Ataxia

Zacks

3 months ago

SLDB Stock Up as FDA Clears IND for SGT-212 in Friedreich's Ataxia

MT Newswires

3 months ago

Truist Initiates Solid Biosciences at Buy With $16 Price Target

MT Newswires

3 months ago

Solid Biosciences' Friedreich's Ataxia Treatment Application Gets FDA Clearance; Shares Rise After Hours

Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia

GlobeNewswire

3 months ago

Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences Added to the Nasdaq Biotechnology Index

GlobeNewswire

3 months ago

Solid Biosciences Added to the Nasdaq Biotechnology Index

Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst

Benzinga

4 months ago

Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst

MT Newswires

4 months ago

Wedbush Initiates Solid Biosciences at Outperform

MT Newswires

4 months ago

Wedbush Initiates Solid Biosciences at Outperform With $16 Price Target

MT Newswires

4 months ago

Solid Biosciences Collaborating With Mayo Clinic to Develop Cardiac Gene Therapies

Solid Biosciences reports inducement grant under Nasdaq listing rule

TipRanks

4 months ago

Solid Biosciences reports inducement grant under Nasdaq listing rule

Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies

GlobeNewswire

4 months ago

Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire

4 months ago

Solid Biosciences to Participate at Upcoming Investor Conferences

Solid Biosciences to Present at the Jefferies London Healthcare Conference

GlobeNewswire

5 months ago

Solid Biosciences to Present at the Jefferies London Healthcare Conference

We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate

Simply Wall St.

5 months ago

We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate

Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire

5 months ago

Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences to Participate at the Truist Securities BioPharma Symposium

GlobeNewswire

5 months ago

Solid Biosciences to Participate at the Truist Securities BioPharma Symposium

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference

GlobeNewswire

6 months ago

Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference

Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference

GlobeNewswire

7 months ago

Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

7 months ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire

7 months ago

Solid Biosciences to Participate at Upcoming Investor Conferences

Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire

8 months ago

Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates

Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

9 months ago

Solid Biosciences Shares Rise After JPMorgan Upgrade

MT Newswires

9 months ago

JPMorgan Upgrades Solid Biosciences to Overweight From Neutral, Adjusts Price Target to $15 From $10

Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

9 months ago

Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

9 months ago

Solid Biosciences Joins Russell 3000 Index

Solid Biosciences Joins the Russell 3000® Index

GlobeNewswire

9 months ago

Solid Biosciences Joins the Russell 3000® Index

MT Newswires

9 months ago

Leerink Partners Upgrades Solid Biosciences to Outperform From Market Perform, Price Target is $12

MT Newswires

9 months ago

Top Premarket Gainers

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

PR Newswire

10 months ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

Enhancing the Power of PTZs: Canon Announces New PTZ Firmware Updates Lending Greater Control and Operability, Including an Auto-Tracking Lite Version on Compatible PTZ Models*

GlobeNewswire

10 months ago

Enhancing the Power of PTZs: Canon Announces New PTZ Firmware Updates Lending Greater Control and Operability, Including an Auto-Tracking Lite Version on Compatible PTZ Models*

Business Wire

10 months ago

Form 8.3 - Darktrace plc

Business Wire

10 months ago

Form 8.3 - International Distribution Services plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Reuters

10 months ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

Investor's Business Daily

10 months ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GlobeNewswire

10 months ago

Middlefield Canadian Income PCC: Net Asset Value(s)

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

10 months ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

10 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

10 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

10 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

10 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

10 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

10 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

10 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

10 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

10 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

10 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

10 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

10 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

10 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

10 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

10 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?

Simply Wall St.

10 months ago

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

We Think Solid Biosciences (NASDAQ:SLDB) Can Afford To Drive Business Growth

Simply Wall St.

10 months ago

We Think Solid Biosciences (NASDAQ:SLDB) Can Afford To Drive Business Growth

Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results

GlobeNewswire

a year ago

Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results

Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting

GlobeNewswire

a year ago

Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug

Zacks

a year ago

Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug

Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

GlobeNewswire

a year ago

Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback

Investor's Business Daily

a year ago

How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback

Solid Biosciences to Participate at Cantor’s Virtual Muscular Dystrophy Symposium

GlobeNewswire

a year ago

Solid Biosciences to Participate at Cantor’s Virtual Muscular Dystrophy Symposium

Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results

GlobeNewswire

a year ago

Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results

Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHD

GlobeNewswire

a year ago

Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHD

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire

a year ago

Solid Biosciences to Participate at Upcoming Investor Conferences

14 Stocks With Heavy Insider Buying In 2024

Insider Monkey

a year ago

14 Stocks With Heavy Insider Buying In 2024

Associated Press Finance

a year ago

Arrow Financial: Q4 Earnings Snapshot

Arrow Reports 4th Quarter Net Income of $7.7 Million or $0.46 per Share and $30.1 Million or $1.77 per Share for 2023. Declares Cash Dividend of $0.27 per Share, its 43rd Consecutive Quarterly Dividend

PR Newswire

a year ago

Arrow Reports 4th Quarter Net Income of $7.7 Million or $0.46 per Share and $30.1 Million or $1.77 per Share for 2023. Declares Cash Dividend of $0.27 per Share, its 43rd Consecutive Quarterly Dividend

Down -14.55% in 4 Weeks, Here's Why You Should You Buy the Dip in Insteel Industries (IIIN)

Zacks

a year ago

Down -14.55% in 4 Weeks, Here's Why You Should You Buy the Dip in Insteel Industries (IIIN)

Share on Social Networks: